Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
2.920
-0.130 (-4.26%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Terns Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 161.44 | 79.93 | 143.24 | 47.7 | 74.85 | Upgrade
|
| Short-Term Investments | 196.73 | 183.51 | 139.88 | 118.28 | - | Upgrade
|
| Cash & Short-Term Investments | 358.16 | 263.44 | 283.11 | 165.98 | 74.85 | Upgrade
|
| Cash Growth | 35.96% | -6.95% | 70.57% | 121.74% | 280.94% | Upgrade
|
| Receivables | - | - | - | - | 12.72 | Upgrade
|
| Prepaid Expenses | 3.95 | 3.99 | 2.07 | 0.95 | 1.16 | Upgrade
|
| Other Current Assets | - | - | - | - | 2.14 | Upgrade
|
| Total Current Assets | 362.11 | 267.43 | 285.19 | 166.93 | 90.87 | Upgrade
|
| Property, Plant & Equipment | 1.47 | 1.03 | 1.8 | 1.05 | 1.18 | Upgrade
|
| Other Long-Term Assets | 0.35 | 0.06 | 0.04 | 0.09 | 0.25 | Upgrade
|
| Total Assets | 363.93 | 268.52 | 287.03 | 168.07 | 92.29 | Upgrade
|
| Accounts Payable | 2.15 | 2.52 | 1.65 | 2.13 | 0.94 | Upgrade
|
| Accrued Expenses | 12.62 | 8.55 | 5.98 | 4.34 | 8.01 | Upgrade
|
| Short-Term Debt | - | - | - | - | 12.88 | Upgrade
|
| Current Portion of Leases | 0.43 | 0.6 | 0.66 | - | - | Upgrade
|
| Other Current Liabilities | 0.46 | 0.28 | 0.19 | 0.36 | 1 | Upgrade
|
| Total Current Liabilities | 15.65 | 11.94 | 8.47 | 6.82 | 22.82 | Upgrade
|
| Long-Term Leases | 0.92 | - | 0.54 | - | - | Upgrade
|
| Other Long-Term Liabilities | 1.49 | 1.21 | 1.07 | 0.95 | 0.88 | Upgrade
|
| Total Liabilities | 18.06 | 13.15 | 10.08 | 7.77 | 23.7 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0 | - | Upgrade
|
| Additional Paid-In Capital | 767.62 | 588.01 | 520.18 | 342.71 | 14.6 | Upgrade
|
| Retained Earnings | -421.48 | -332.63 | -242.42 | -182.07 | -131.92 | Upgrade
|
| Comprehensive Income & Other | -0.28 | -0.02 | -0.82 | -0.34 | -0.12 | Upgrade
|
| Total Common Equity | 345.87 | 255.37 | 276.94 | 160.3 | -117.44 | Upgrade
|
| Shareholders' Equity | 345.87 | 255.37 | 276.94 | 160.3 | 68.59 | Upgrade
|
| Total Liabilities & Equity | 363.93 | 268.52 | 287.03 | 168.07 | 92.29 | Upgrade
|
| Total Debt | 1.35 | 0.6 | 1.21 | - | 12.88 | Upgrade
|
| Net Cash (Debt) | 356.82 | 262.84 | 281.91 | 165.98 | 61.97 | Upgrade
|
| Net Cash Growth | 35.76% | -6.77% | 69.84% | 167.82% | 215.39% | Upgrade
|
| Net Cash Per Share | 4.49 | 3.69 | 7.82 | 7.31 | 217.33 | Upgrade
|
| Filing Date Shares Outstanding | 87.3 | 64.65 | 56.67 | 25.27 | 25.13 | Upgrade
|
| Total Common Shares Outstanding | 87.13 | 64.58 | 53.72 | 25.27 | 0.34 | Upgrade
|
| Working Capital | 346.46 | 255.49 | 276.72 | 160.11 | 68.05 | Upgrade
|
| Book Value Per Share | 3.97 | 3.95 | 5.16 | 6.34 | -347.97 | Upgrade
|
| Tangible Book Value | 345.87 | 255.37 | 276.94 | 160.3 | -117.44 | Upgrade
|
| Tangible Book Value Per Share | 3.97 | 3.95 | 5.16 | 6.34 | -347.97 | Upgrade
|
| Machinery | 1.36 | 1.38 | 1.4 | 1.3 | 0.97 | Upgrade
|
| Leasehold Improvements | 0.75 | 0.73 | 0.76 | 0.93 | 0.9 | Upgrade
|
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.